Hospital Acquired Infections Testing Kits Market: Growing to $6.42 Billion by 2028, Fueled by Rising HAIs and Advancements in Diagnostic Technologies

The hospital acquired infections testing kits market size has grown strongly in recent years. It will grow from $4.35 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increase in increased hospital-acquired infections (hais), increased aging population and increased number of surgeries.

The hospital acquired infections testing kits market size is expected to see strong growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to the increase in chronic diseases, a rise in healthcare expenditure and increasing government support will drive the growth. Major trends in the forecast period include collaborating with artificial intelligence companies, leveraging aid from government, incorporating big data into their market analysis and partnering with other players in the market.

Market Overview -
The hospital-acquired infection testing kits are tools used to check the infections people get while in a healthcare facility. Hospital-acquired infections testing kits are used to check the infections associated with pathogens such as vancomycin-resistant enterococci (VRE), methicillin-resistant staphylococcus aureus (MRSA), multi-resistant gram-negative bacilli, norovirus, and Clostridium difficile.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

Rising Incidence Of Hospital-Acquired Infections Fuels Growth In Hospital Acquired Infections Testing Kits Market
The hospital-acquired infections (HAIs) are on the rise, affecting both the inpatients and outpatients. Hospital-acquired infections or nosocomial infections are diseases that are acquired in hospitals and medical clinics. For example, according to the findings by the Center for Disease Control and Prevention, around 1.7 million people in the USA acquire hospital-acquired infections caused while being admitted for other health issues and more than 98,000 (around 5%) patients die due to these infections. The increasing incidence of hospital-acquired infections leads to an increase in the demand for hospital-acquired infections testing kits market.

Competitive Landscape -
Major companies operating in the hospital acquired infections testing kits market report are Becton, Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, Hologic, Inc, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, Metall Zug (Belimed Group), Innovaccer, JD Health, CISCO Systems Inc, GE Healthcare, Honeywell Lifesciences, Zydus Cadila, ImmunoScience, CPC Diagnostics, Seegene, SD Biosensor, Vivacheck Lab, Fujirebio, Sysmex Corporation, Philip Healthcare, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Bayer AG, Cantel Medical Corporation, BioMérieux, Siemens Healthineers

Advancements In Diagnostic Tests For Hais
The diagnostic tests involved in diagnosing HAIs such as flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based technologies are advancing in technologies, providing more accurate data. There has been a significant advancement in mass spectrometers, which quantifies known materials, and identifies unknown compounds within a sample. For instance, SCIEX's X500 QTOF solves the challenge of contamination and is a compact device that does not compromise on resolution and accuracy. It gives results sooner and allows the operator to make data-driven decisions sooner.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Key Segments -
The hospital acquired infections testing kits market covered in this report is segmented -
1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.